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216 S ummary and c o nc lus io ns
In this thesis a number of studies are described concerning the dynamics of the
allergic reaction in airways and skin. Two intervention methods were used: Repeated
allergen challenge and systemic allergen immunotherapy. The following research
questions are central in this thesis:
l- Dynamics of the allergic reaction:
a) What is the effect of repeated allergen challenge on allergic reactions in the
nose and skin in individual patients?
b) What is the effect of immunotherapy on the response pattern to repeated
allergen challenge?
c) Does repeated allergen challenge provide information on the regulation of
the allergic reaction?
2- Can the allergic skin reaction be used as a model for allergic reactions in the
airways in the evaluation of immunotherapy.
The patients who were investigated in the different studies were allergic and suffered
from asthma and/or rhinitis. Definitions and prevalences of allergy (1.1), asthma (1.2)
and rhinitis(l.3) in the Netherlands are described in chapter l. In addition a table
concerning the classification of the severity of astma is added.
In chapter 2 different aspects of the allergic reaction are described. Chapter 2.1 deals
with the physiological responses to allergen challenge in the lower airways and nose.
Experimental allergen challenge in the lower airways (2.1.1) frequently results in dual
responses. The fall in FEVI value is a sensitive method to measure early and late
allergic reactions.In the nose (2.1.2), the large variety in investigation methods, used
for the documentation of allergic responses, results in a large variation in reported
numbers of late phase reactions. The subtle changes in nasal patency during late
phase responses can only be detected with very sensitive methods.
Chapter 2.2 deals with the immunohistology of the allergic reaction in the airways.
Cells, which are involved in the effector phase and the regulation of the allergic
reaction are described separately (2.2.2). Mast cells are important effector cells in the
early phase reaction through the release of various mediators and can play a role in
initiating inflammatory responses by the release of cytokines. Late phase
inflammatory reactions are caused by products derived from inflammatory cells, such
as eosinophils, neutrophils and basophils. Different subsets of T-lymphocytes play an
important role in regulating allergic inflammation. Antigen pÍesenting cells are
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In chapter 2.3 a short overview of neuroregulation of the nose and bronchi is given.
Sympathetic and parasympathetic components of the nervous system control airway
vasculature, secretory glands and airway smooth muscle.
Differences between allergic manifestations in nose and bronchi are described in
chapter 2.4. The different manifestation of allergic reactions in nose and lower
airways can probably be explained by a different "translation" from inflammatory
pÍocesses into physiological changes and symptoms.
In chapter 2.5 macroscopy and immunohistology of the early and late allergic
reaction in the skin after intradermal challenge is described. Allergic inflammation is
caused by products derived from infiltrating effector cells such as eosinophils,
basophils and neutrophils. In addition, T-lymphocytes have regulating effects on the
inflammatory response .
When comparing allergic reactions in the airways and the skin (chapter 2,6), the
microscopic hanges during the late allergic skin reaction after intradermal challenge
seem to resemble the microscopic hanges during allergen-induced inflammatory
responses in the airways. However the macroscopic expression of allergic reactions
in airways and skin is quite different.
Chapter 3 deals with the dynamics of the allergic reaction. Effects of repeated or
chronic allergen exposition in nose (3.2.1),lower airways (3.2.2) and skin (3.2.3) are
described. In chapter 3.3 a short overview of systemic allergen immunotherapy is
given.
In order to address the research questions the documentation of allergen-induced
reactions in the airways and nose was optimised. In chapter 5 technical and
methodological aspects of bronchial challenge tests with inhalant allergens are
described. FEVr values after allergen challenge should be corrected for diurnal
variation and a follow-up period after allergen challenge of at least l0 hours is
necessary. In chapter 6 a new, non-invasive, technique was developed to register
allergen-induced early and late reactions in the nose. In addition criteria were
suggested for the definition of early and late phase nasal reactions.
In chapter 7 the effect of Cetirizine was studied on early and late asthmatic reactions
after experimental allergen challenge in l6 housedustmite allergic asthmatic patients.
In addition effects on blood ECP levels and PCzo methacholine were studied.
Eighteen days of treatment with Cetirizine did not significantly reduce the intensity
of the early and late asthmatic response. There was also no significant effect on the
blood ECP levels and PCzo methacholine.
z t  I
2t8 Summary and conclusions
In chapter 8 the effect of allergen challenge on airway responsiveness to histamine
was investigated in 2l atopic asthmatic patients. Depending on baseline PC26
histamine, a significant decrease in PC2s histamine was only found in patients with
relatively high baseline PCzo histamine. A significant inverse correlation was found
between baseline PCzo and allergen-induced change in PCzo histamine. In addition
the effect of repeated allergen challenge on early and late asthmatic rations and on
airway responsiveness was studied in 8 patients. Repeated allergen challenge with an
interval of 48 hours did not result in significant changes in early and late asthmatic
reactions. The first allergen challenge resulted in a significant decrease in PC26
histamine; no further decrease in mean PC2g histamine was seen after the second
allergen challenge.
In chapter 9 repeated intradermal challenge with housedustmite resulted in a
significant increase in late phase skin reactions at 6, 24 and 48 hours in 13
housedustmite allergic patients. CD4+ T-lymphocytes and eosinophils were increased
up to 96 hours after challenge.
In chapter I I repeated intradermal challenges with housedustmite were performed
before and after I year of immunotherapy with a standardised housedustmite xtract
(SQ 503) in l0 patients, allergic to housedustmite. Immunotherapy resulted in a
significant decrease in late skin reaction; in addition repeated allergen challenge after
immunotherapy resulted in a further significant decrease in late reaction diameter,
when challenge 3 was compared to challenge 1 In the skin biopsies, taken 24 hours
after the first challenge, a significant increase in the percentage of CD8+ and CD25+
cells was found after immunotherapy compared to before, while there was no
significant change in mean overall mononuclear cell density.
Repeated allergen challenges with grasspollen in the nose and skin of I I grasspollen
allergic patients did not result in significant overall changes in early and late allergic
responses in both organs (chapter l0). Large individual differences in response
patterns were found. A significant correlation was found between the effect of
repeated allergen challenge on the late response in the nose and the skin, suggesting
that the late response pattern to repeated allergen challenge may be a characteristic
of the individual patient.
In chapter 12 the relationship between the effect of immunotherapy with a
standardised housedustmite xtract (SQ 503) on allergic reactions in the airways
compared to the skin was investigated in l0 housedustmite allergic patients with
asthma. Immunotherapy resulted in a significant decrease in early and late allergic



































































allergic reactions in the airways could not be predicted from effects on early or late
skin reactions or from effects on skin reactions, corrected for effects on PCzo
histamine.
Correlations between the effect of immunotherapy on allergic reactions in the nose
and the skin were investigated in chapter 13. Repeated nasal challenges and
intradermal challenges with grasspollen were performed in l l grasspollen allergic
patients before and after I year of immunotherapy with a standardised grasspollen
extract (SQ 293). Immunotherapy resulted in a significant decrease in early and late
allergic reactions in nose and skin. No significant correlations were found between
the effect of immunotherapy on allergic reactions in the nose and the skin for early
and late responses. When using the model of repeated allergen challenge, the effect
of immunotherapy on the late phase response pattern to repeated allergen challenge
in the skin was significantly conelated with the effect of immunotherapy on early and
late phase response pattern after repeated allergen challenge in the nose.
Conclusions
l) Dynamics of the allergic reaction
- Repeated allergen challenge in nose and skin in individual patients can lead to
priming as well as to downregulation of the allergic reaction. The late phase
response pattern to repeated allergen challenge seems to be a characteristic of
the individual patient.
- Repeated allergen challenge in the skin after immunotherapy results in a
significant decrease in late phase diameter. This response pattern can possibly be
explained by suppressive actions of CD8+ T-cells.
2) The allergic skin reaction as a model for allergic reactions in the airways in the
evaluation of immunotherapy
- The effect of immunotherapy on allergic reactions skin and airwavs is not
significantly correlated.
- The effect of immunotherapy on late phase response patterns to repeated allergen
challenge in nose and skin is significantly conelated.
- When allergic skin reactions are used in the evaluation of the effect of allergen
immunotherapy on allergic reactions in the airways, it seems better to use late
phase reponse patterns to repeated allergen challenge.
